Meet the women honored as the 2025 Western Slope Women of Distinction
The 2025 honorees were selected by a committee of previous Women of Distinction (WoD) honorees. WoD picked this year's women based on their personal and professional contributions to the community. The Western Slope WoD has currently been awarded to over 30 women.
The Girl Scouts of Colorado has honored Lisa Martin, Helen Roe, and Laurel Walters for the 2025 Western Slope WoD.
'It's an honor to welcome this year's Women of Distinction,' said Leanna Clark, chief executive officer of Girl Scouts of Colorado. 'These women are powerful examples of leadership and excellence, and their strength, boldness, and empowerment make them outstanding role models who inspire our girls and power today's world.'
Lisa Martin is the founder of her own consulting business, Lisa D Martin, and works with Ariel Clinical Services and other organizations. Before founding her business in 2019, Martin worked in various roles for over 50 years, helping individuals. These roles include working in the Department of Human Services for over 30 years in adult services, Employment First eligibility services, and adolescent services for youth aging out of the foster care system. Martin has served for over 15 years as the Vice President of Human Resources at Hilltop Community Resources before working for four years as a human resources manager at Ariel Clinical Services. Her career experiences have taught her about aging, unemployment struggles, and the pressures and uncertainty of losing support systems.
Helen Roe is the director of the Business Loan Fund of Mesa County as part of the Business Incubator Center. After over two decades as an entrepreneur on the Front Range, Roe moved to Grand Junction and earned her degrees in marketing and accounting at Colorado Mesa University. She was offered an internship at the Business Incubator Center and remained at the company, working her way up, for 19 years. She was named the State of Colorado Small Business Development Center Counselor of the Year in 2011. Currently, Roe is also a small business coach specializing in accounting, finance, and strategic business planning. Roe is a former member of the Mesa County Executive Fair Board and currently serves on the Advisory Board of the Grand Junction Housing Authority Family Self-Sufficiency program.
Laurel Walters had moved to Grand Junction to become the chief operating officer for Rocky Mountain Health Plans after her early career as a Denver health plan's legislative affairs director. After her retirement in 2020, Walters has volunteered over 3,000 hours at the Grand Junction Police Department's Victim Services Program. In 2024, Walters received the Carol Hacker Award for Outstanding Victim Advocate in the Volunteer Sector from the Colorado Organization for Victim Assistance. Her work has reportedly made a difference in many lives and contributes to the Grand Junction Police Department's mission of offering emotional support and resources to victims of crime.
The Girl Scouts of Colorado will be hosting an honor ceremony to celebrate the 2025 Western Slope WoD honorees from 7:30 a.m. to 9:30 a.m. on Friday, October 31, at Colorado Mesa University. The proceeds from the ceremony will support Girl Scouts of Colorado's leadership development programs in entrepreneurship, outdoors, STEM, and life skills for over 1,800 Girl Scouts across the Western Slope.
Individuals interested in purchasing tickets or becoming a sponsor can contact Becky Grupe at Becky.Grupe@gscolorado.org.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
JD.com, Inc.'s (NASDAQ:JD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
It is hard to get excited after looking at (NASDAQ:JD) recent performance, when its stock has declined 2.2% over the past week. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. In this article, we decided to focus on ROE. Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In short, ROE shows the profit each dollar generates with respect to its shareholder investments. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. How Is ROE Calculated? Return on equity can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for is: 16% = CN¥49b ÷ CN¥309b (Based on the trailing twelve months to March 2025). The 'return' is the profit over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.16. Check out our latest analysis for Why Is ROE Important For Earnings Growth? We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes. Earnings Growth And 16% ROE At first glance, seems to have a decent ROE. Even when compared to the industry average of 16% the company's ROE looks quite decent. Consequently, this likely laid the ground for the decent growth of 8.6% seen over the past five years by Next, on comparing with the industry net income growth, we found that reported growth was lower than the industry growth of 12% over the last few years, which is not something we like to see. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry. Is Making Efficient Use Of Its Profits? has a healthy combination of a moderate three-year median payout ratio of 31% (or a retention ratio of 69%) and a respectable amount of growth in earnings as we saw above, meaning that the company has been making efficient use of its profits. While has been growing its earnings, it only recently started to pay dividends which likely means that the company decided to impress new and existing shareholders with a dividend. Upon studying the latest analysts' consensus data, we found that the company's future payout ratio is expected to drop to 22% over the next three years. However, the company's ROE is not expected to change by much despite the lower expected payout ratio. Summary Overall, we are quite pleased with performance. Specifically, we like that the company is reinvesting a huge chunk of its profits at a high rate of return. This of course has caused the company to see a good amount of growth in its earnings. With that said, the latest industry analyst forecasts reveal that the company's earnings growth is expected to slow down. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
5 hours ago
- Yahoo
Declining Stock and Solid Fundamentals: Is The Market Wrong About Abbott Laboratories (NYSE:ABT)?
It is hard to get excited after looking at Abbott Laboratories' (NYSE:ABT) recent performance, when its stock has declined 5.8% over the past month. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive long-term market outcomes, the company is worth looking at. Particularly, we will be paying attention to Abbott Laboratories' ROE today. Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. Simply put, it is used to assess the profitability of a company in relation to its equity capital. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. How Is ROE Calculated? Return on equity can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Abbott Laboratories is: 28% = US$14b ÷ US$49b (Based on the trailing twelve months to June 2025). The 'return' is the profit over the last twelve months. Another way to think of that is that for every $1 worth of equity, the company was able to earn $0.28 in profit. See our latest analysis for Abbott Laboratories What Has ROE Got To Do With Earnings Growth? So far, we've learned that ROE is a measure of a company's profitability. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes. Abbott Laboratories' Earnings Growth And 28% ROE To begin with, Abbott Laboratories has a pretty high ROE which is interesting. Secondly, even when compared to the industry average of 12% the company's ROE is quite impressive. This likely paved the way for the modest 17% net income growth seen by Abbott Laboratories over the past five years. As a next step, we compared Abbott Laboratories' net income growth with the industry and found that the company has a similar growth figure when compared with the industry average growth rate of 15% in the same period. Earnings growth is a huge factor in stock valuation. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. This then helps them determine if the stock is placed for a bright or bleak future. Has the market priced in the future outlook for ABT? You can find out in our latest intrinsic value infographic research report. Is Abbott Laboratories Making Efficient Use Of Its Profits? Abbott Laboratories has a significant three-year median payout ratio of 59%, meaning that it is left with only 41% to reinvest into its business. This implies that the company has been able to achieve decent earnings growth despite returning most of its profits to shareholders. Additionally, Abbott Laboratories has paid dividends over a period of at least ten years which means that the company is pretty serious about sharing its profits with shareholders. Upon studying the latest analysts' consensus data, we found that the company's future payout ratio is expected to drop to 41% over the next three years. Regardless, the future ROE for Abbott Laboratories is predicted to decline to 20% despite the anticipated decrease in the payout ratio. We reckon that there could probably be other factors that could be driving the forseen decline in the company's ROE. Summary Overall, we are quite pleased with Abbott Laboratories' performance. Especially the high ROE, Which has contributed to the impressive growth seen in earnings. Despite the company reinvesting only a small portion of its profits, it still has managed to grow its earnings so that is appreciable. That being so, according to the latest industry analyst forecasts, the company's earnings are expected to shrink in the future. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
9 hours ago
- Yahoo
Is International Consolidated Airlines Group S.A.'s (LON:IAG) ROE Of 47% Impressive?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). We'll use ROE to examine International Consolidated Airlines Group S.A. (LON:IAG), by way of a worked example. Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In simpler terms, it measures the profitability of a company in relation to shareholder's equity. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. How To Calculate Return On Equity? The formula for ROE is: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for International Consolidated Airlines Group is: 47% = €2.9b ÷ €6.2b (Based on the trailing twelve months to March 2025). The 'return' is the income the business earned over the last year. That means that for every £1 worth of shareholders' equity, the company generated £0.47 in profit. Check out our latest analysis for International Consolidated Airlines Group Does International Consolidated Airlines Group Have A Good Return On Equity? By comparing a company's ROE with its industry average, we can get a quick measure of how good it is. Importantly, this is far from a perfect measure, because companies differ significantly within the same industry classification. Pleasingly, International Consolidated Airlines Group has a superior ROE than the average (28%) in the Airlines industry. That's clearly a positive. Bear in mind, a high ROE doesn't always mean superior financial performance. A higher proportion of debt in a company's capital structure may also result in a high ROE, where the high debt levels could be a huge risk . To know the 2 risks we have identified for International Consolidated Airlines Group visit our risks dashboard for free. How Does Debt Impact ROE? Virtually all companies need money to invest in the business, to grow profits. That cash can come from retained earnings, issuing new shares (equity), or debt. In the first two cases, the ROE will capture this use of capital to grow. In the latter case, the debt required for growth will boost returns, but will not impact the shareholders' equity. That will make the ROE look better than if no debt was used. International Consolidated Airlines Group's Debt And Its 47% ROE International Consolidated Airlines Group clearly uses a high amount of debt to boost returns, as it has a debt to equity ratio of 2.81. Its ROE is pretty impressive but, it would have probably been lower without the use of debt. Investors should think carefully about how a company might perform if it was unable to borrow so easily, because credit markets do change over time. Summary Return on equity is one way we can compare its business quality of different companies. In our books, the highest quality companies have high return on equity, despite low debt. If two companies have the same ROE, then I would generally prefer the one with less debt. But ROE is just one piece of a bigger puzzle, since high quality businesses often trade on high multiples of earnings. It is important to consider other factors, such as future profit growth -- and how much investment is required going forward. So I think it may be worth checking this free report on analyst forecasts for the company. If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
